GLP-1 treatment has been reported to alleviate diabetic retinopathy by inhibiting hyperglycemia-provoked autophagy in the retina of T2D rats mediated through the restoration of GLP-1R expression and HDAC6 inhibition [256]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.